EPA0054 P400/Tip60 chromatin remodeling complex in HIV transcription and latency establishmentE-posterUnderstanding and targeting persistent HIV reservoirs
EPD0695 Parent/guardians knowledge, attitudes and perceptions on long acting injectable cabotegravir (CAB LA) for HIV prevention and study participation in HPTN 084-01 study: tales from Mu-JHU, Kampala siteE-posterKey populations and other vulnerable populations: Behavioural, social and cultural issues and contexts
EPC0395 Parrying the pitfalls of PrEP: preventing premature PrEP discontinuation and STIs among men who have sex with menE-posterHIV prevention research
EPD0531 Participant perspectives on incentives for TB preventative therapy adherence and reduced alcohol use: a qualitative studyE-posterSocial science theories, concepts and methods
EPB0216 Participant-reported outcomes with long-acting lenacapavir-based regimens among heavily treatment-experienced people living with HIV in the CAPELLA clinical trialE-posterAntiretroviral therapies and clinical issues in adults
EPC0303 Past-year transactional sex associated with HIV and STIs among MSM in the U.S.: findings from the American Men’s Internet Survey, 2017-2021E-posterEpidemiology of HIV
MOPEA09 Patient-derived envelope sequences are differentially resistant to SERINC5-mediated restriction of HIV-1 infectivityPoster exhibitionHost immune responses, vaccines and immunotherapies
TUPEB06 Patient-reported outcomes after 12 months of maintenance therapy with cabotegravir + rilpivirine long-acting compared with bictegravir/emtricitabine/tenofovir alafenamide in the Phase 3b SOLAR studyPoster exhibitionAntiretroviral therapies and clinical issues in adults
EPE0846 Pediatric advanced HIV disease landscape: outcomes from an assessment in UgandaE-posterImplementation science and scale up of treatment
MOPEC15 Peer influence on Latino sexual minority men's motivation to use PrEP in Miami, FloridaPoster exhibitionHIV prevention research
961 - 970 of 1427 items